There is new evidence that a 50-year-old blood pressure drug could find new purpose as a treatment to mitigate the often life-altering effects of increasingly prevalent PTSD, scientists say.
Jan 5, 2023
2
94
The post-COVID syndrome known as long COVID has four major subtypes defined by different clusters of symptoms, according to a study led by researchers at Weill Cornell Medicine.
Jan 4, 2023
0
107
Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease ...
Dec 20, 2022
0
83
Initial data from a University of Cincinnati clinical research study aimed at increasing diet quality and decreasing cardiovascular risk shows positive results.
Dec 13, 2022
0
41
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new study published in The Lancet Infectious ...
Nov 29, 2022
0
100
Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for ...
Nov 18, 2022
0
57
COVID-19 vaccines and drugs were developed at "warp speed" and now experts are concerned about the US Food and Drug Administration's (FDA) inadequate surveillance of clinical trial sites, reports an investigation published ...
Nov 16, 2022
0
84
Testing whether a new drug impacts the progression of Parkinson's disease takes years, in part because the disease often advances so slowly. Many Parkinson's patients don't have any worsening of their symptoms over the course ...
Nov 10, 2022
0
18
A monoclonal antibody that targets heroin is effective in blocking the psychoactive and lethal effects of this drug of abuse in mice—offering a new strategy for heroin addiction and overdose treatment, according to a new ...
Oct 26, 2022
0
45
Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic option for infections with ...
Oct 24, 2022
1
217
